Annual Net Income:
-$4.03M-$57.85M(-107.49%)Summary
- As of today, LGND annual net profit is -$4.03 million, with the most recent change of -$57.85 million (-107.49%) on December 31, 2024.
- During the last 3 years, LGND annual net income has fallen by -$80.39 million (-105.28%).
- LGND annual net income is now -100.64% below its all-time high of $629.30 million, reached on December 31, 2019.
Performance
LGND Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Net Income:
$4.85M+$47.30M(+111.42%)Summary
- As of today, LGND quarterly net profit is $4.85 million, with the most recent change of +$47.30 million (+111.42%) on June 30, 2025.
- Over the past year, LGND quarterly net income has increased by +$56.76 million (+109.34%).
- LGND quarterly net income is now -99.27% below its all-time high of $666.34 million, reached on March 31, 2019.
Performance
LGND Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Net Income:
-$75.86M+$56.76M(+42.80%)Summary
- As of today, LGND TTM net profit is -$75.86 million, with the most recent change of +$56.76 million (+42.80%) on June 30, 2025.
- Over the past year, LGND TTM net income has dropped by -$118.01 million (-280.02%).
- LGND TTM net income is now -109.92% below its all-time high of $764.38 million, reached on March 31, 2019.
Performance
LGND TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
LGND Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -107.5% | +109.3% | -280.0% |
| 3Y3 Years | -105.3% | -61.5% | -843.8% |
| 5Y5 Years | -100.6% | -78.0% | -370.9% |
LGND Net Income Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -105.3% | +22.7% | -94.4% | +109.3% | -178.7% | +42.8% |
| 5Y | 5-Year | -100.6% | +22.7% | -94.4% | +109.3% | -178.7% | +42.8% |
| All-Time | All-Time | -100.6% | +97.0% | -99.3% | +103.4% | -109.9% | +57.1% |
LGND Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $4.85M(+111.4%) | -$75.86M(+42.8%) |
| Mar 2025 | - | -$42.45M(-36.6%) | -$132.62M(-3189.2%) |
| Dec 2024 | -$4.03M(-107.5%) | -$31.09M(-333.5%) | -$4.03M(-108.9%) |
| Sep 2024 | - | -$7.17M(+86.2%) | $45.24M(+7.4%) |
| Jun 2024 | - | -$51.91M(-160.3%) | $42.14M(-56.3%) |
| Mar 2024 | - | $86.14M(+373.6%) | $96.34M(+79.0%) |
| Dec 2023 | $53.82M(+1131.2%) | $18.19M(+277.0%) | $53.82M(+155.1%) |
| Sep 2023 | - | -$10.27M(-548.6%) | $21.10M(-48.6%) |
| Jun 2023 | - | $2.29M(-94.7%) | $41.02M(-20.1%) |
| Mar 2023 | - | $43.61M(+400.1%) | $51.32M(+1083.4%) |
| Dec 2022 | -$5.22M(-106.8%) | -$14.53M(-250.7%) | -$5.22M(-185.3%) |
| Sep 2022 | - | $9.64M(-23.4%) | $6.12M(-40.0%) |
| Jun 2022 | - | $12.60M(+197.4%) | $10.20M(-64.0%) |
| Mar 2022 | - | -$12.93M(-304.8%) | $28.32M(-52.3%) |
| Dec 2021 | $76.35M(+2657.9%) | -$3.19M(-123.3%) | $59.36M(-13.1%) |
| Sep 2021 | - | $13.72M(-55.3%) | $68.31M(+42.6%) |
| Jun 2021 | - | $30.73M(+69.7%) | $47.89M(+22.0%) |
| Mar 2021 | - | $18.11M(+214.3%) | $39.25M(+1415.0%) |
| Dec 2020 | -$2.98M(-100.5%) | $5.76M(+186.0%) | -$2.98M(+81.5%) |
| Sep 2020 | - | -$6.70M(-130.3%) | -$16.11M(+34.7%) |
| Jun 2020 | - | $22.09M(+191.5%) | -$24.66M(+59.7%) |
| Mar 2020 | - | -$24.13M(-227.6%) | -$61.17M(-109.7%) |
| Dec 2019 | $629.30M(+339.1%) | -$7.37M(+51.7%) | $629.30M(+5.9%) |
| Sep 2019 | - | -$15.25M(-5.8%) | $594.18M(-12.2%) |
| Jun 2019 | - | -$14.42M(-102.2%) | $676.80M(-11.5%) |
| Mar 2019 | - | $666.34M(+1668.5%) | $764.38M(+433.3%) |
| Dec 2018 | $143.32M(+1041.5%) | -$42.48M(-163.1%) | $143.32M(-19.8%) |
| Sep 2018 | - | $67.36M(-7.9%) | $178.79M(+49.2%) |
| Jun 2018 | - | $73.16M(+61.6%) | $119.86M(+127.2%) |
| Mar 2018 | - | $45.28M(+745.9%) | $52.75M(+320.2%) |
| Dec 2017 | $12.56M(+630.5%) | -$7.01M(-183.2%) | $12.55M(-23.6%) |
| Sep 2017 | - | $8.43M(+39.1%) | $16.44M(+81.4%) |
| Jun 2017 | - | $6.06M(+19.3%) | $9.06M(+386.2%) |
| Mar 2017 | - | $5.08M(+262.5%) | -$3.17M(-33.7%) |
| Dec 2016 | -$2.37M(-101.0%) | -$3.13M(-397.4%) | -$2.37M(-133.4%) |
| Sep 2016 | - | $1.05M(+117.0%) | $7.10M(-96.5%) |
| Jun 2016 | - | -$6.17M(-205.0%) | $205.21M(-12.1%) |
| Mar 2016 | - | $5.88M(-7.3%) | $233.41M(+2.6%) |
| Dec 2015 | $227.44M(+1988.2%) | $6.34M(-96.8%) | $227.44M(-0.2%) |
| Sep 2015 | - | $199.16M(+804.2%) | $227.84M(+673.7%) |
| Jun 2015 | - | $22.03M(>+9900.0%) | $29.45M(+238.1%) |
| Mar 2015 | - | -$89.00K(-101.3%) | $8.71M(-20.1%) |
| Dec 2014 | $10.89M(+23.3%) | $6.73M(+766.5%) | $10.89M(+80.6%) |
| Sep 2014 | - | $777.00K(-39.7%) | $6.03M(-16.5%) |
| Jun 2014 | - | $1.29M(-38.6%) | $7.22M(-25.0%) |
| Mar 2014 | - | $2.10M(+12.2%) | $9.63M(+9.0%) |
| Dec 2013 | $8.83M(+430.3%) | $1.87M(-4.9%) | $8.83M(-7.5%) |
| Sep 2013 | - | $1.97M(-46.8%) | $9.55M(+29.2%) |
| Jun 2013 | - | $3.69M(+183.3%) | $7.39M(+2097.3%) |
| Mar 2013 | - | $1.30M(-49.6%) | -$370.00K(+82.9%) |
| Dec 2012 | -$2.67M(-127.5%) | $2.59M(+1433.0%) | -$2.16M(-835.0%) |
| Sep 2012 | - | -$194.00K(+95.2%) | $294.00K(+108.0%) |
| Jun 2012 | - | -$4.07M(-734.9%) | -$3.69M(-585.9%) |
| Mar 2012 | - | -$487.00K(-109.7%) | -$538.00K(-105.4%) |
| Dec 2011 | $9.71M(+176.0%) | $5.04M(+220.7%) | $9.98M(+5.7%) |
| Sep 2011 | - | -$4.18M(-357.1%) | $9.44M(+432.1%) |
| Jun 2011 | - | -$914.00K(-109.1%) | $1.77M(-26.2%) |
| Mar 2011 | - | $10.03M(+122.7%) | $2.40M(+122.7%) |
| Dec 2010 | -$12.79M(-53.4%) | $4.50M(+138.0%) | -$10.61M(+24.7%) |
| Sep 2010 | - | -$11.84M(-4084.8%) | -$14.08M(-1087.5%) |
| Jun 2010 | - | -$283.00K(+90.5%) | -$1.19M(+78.0%) |
| Mar 2010 | - | -$2.99M(-389.9%) | -$5.38M(+45.5%) |
| Dec 2009 | -$8.34M | $1.03M(-2.3%) | -$9.87M(+88.3%) |
| Sep 2009 | - | $1.05M(+123.6%) | -$84.63M(+10.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2009 | - | -$4.48M(+40.2%) | -$94.81M(+0.4%) |
| Mar 2009 | - | -$7.48M(+89.9%) | -$95.22M(+2.3%) |
| Dec 2008 | -$97.46M(-180.4%) | -$73.73M(-708.1%) | -$97.46M(-235.5%) |
| Sep 2008 | - | -$9.12M(-86.6%) | -$29.05M(-17.2%) |
| Jun 2008 | - | -$4.89M(+49.7%) | -$24.79M(+10.1%) |
| Mar 2008 | - | -$9.72M(-82.6%) | -$27.59M(+20.6%) |
| Dec 2007 | -$34.76M(+74.4%) | -$5.32M(-9.5%) | -$34.76M(-410.5%) |
| Sep 2007 | - | -$4.86M(+36.7%) | $11.19M(>+9900.0%) |
| Jun 2007 | - | -$7.69M(+54.5%) | -$86.00K(+99.0%) |
| Mar 2007 | - | -$16.89M(-141.6%) | -$8.36M(+93.7%) |
| Dec 2006 | -$135.86M(-273.2%) | $40.63M(+351.7%) | -$133.70M(+24.5%) |
| Sep 2006 | - | -$16.14M(-1.1%) | -$177.05M(-5.9%) |
| Jun 2006 | - | -$15.96M(+88.8%) | -$167.19M(-4.4%) |
| Mar 2006 | - | -$142.23M(-5125.2%) | -$160.16M(-340.0%) |
| Dec 2005 | -$36.40M(+19.4%) | -$2.72M(+56.7%) | -$36.40M(-122.7%) |
| Sep 2005 | - | -$6.28M(+29.6%) | -$16.34M(+42.8%) |
| Jun 2005 | - | -$8.92M(+51.7%) | -$28.56M(+31.5%) |
| Mar 2005 | - | -$18.47M(-206.6%) | -$41.70M(+7.6%) |
| Dec 2004 | -$45.14M(-27.3%) | $17.33M(+193.7%) | -$45.14M(+17.2%) |
| Sep 2004 | - | -$18.50M(+16.2%) | -$54.53M(-15.7%) |
| Jun 2004 | - | -$22.07M(-0.7%) | -$47.12M(-27.2%) |
| Mar 2004 | - | -$21.91M(-375.7%) | -$37.05M(-4.5%) |
| Dec 2003 | -$35.46M(-8.8%) | $7.95M(+171.7%) | -$35.46M(+29.3%) |
| Sep 2003 | - | -$11.09M(+7.6%) | -$50.13M(-8.8%) |
| Jun 2003 | - | -$12.00M(+41.0%) | -$46.09M(+0.5%) |
| Mar 2003 | - | -$20.32M(-202.0%) | -$46.34M(-42.2%) |
| Dec 2002 | -$32.60M(+24.2%) | -$6.73M(+4.5%) | -$32.60M(+16.3%) |
| Sep 2002 | - | -$7.05M(+42.5%) | -$38.92M(+1.8%) |
| Jun 2002 | - | -$12.25M(-86.3%) | -$39.62M(-4.3%) |
| Mar 2002 | - | -$6.58M(+49.6%) | -$37.99M(+11.6%) |
| Dec 2001 | -$42.99M(+27.5%) | -$13.05M(-68.6%) | -$42.99M(-0.8%) |
| Sep 2001 | - | -$7.74M(+27.0%) | -$42.64M(+14.4%) |
| Jun 2001 | - | -$10.62M(+8.3%) | -$49.83M(+10.5%) |
| Mar 2001 | - | -$11.58M(+8.8%) | -$55.67M(+5.7%) |
| Dec 2000 | -$59.28M(+20.7%) | -$12.70M(+14.9%) | -$59.04M(+14.7%) |
| Sep 2000 | - | -$14.93M(+9.3%) | -$69.20M(+4.7%) |
| Jun 2000 | - | -$16.46M(-10.1%) | -$72.58M(+3.4%) |
| Mar 2000 | - | -$14.96M(+34.6%) | -$75.11M(-0.5%) |
| Dec 1999 | -$74.72M(+36.6%) | -$22.86M(-24.9%) | -$74.72M(+19.2%) |
| Sep 1999 | - | -$18.31M(+3.6%) | -$92.52M(+23.2%) |
| Jun 1999 | - | -$18.99M(-30.5%) | -$120.49M(-1.3%) |
| Mar 1999 | - | -$14.56M(+64.2%) | -$118.90M(-0.9%) |
| Dec 1998 | -$117.89M(-17.7%) | -$40.66M(+12.1%) | -$117.88M(+18.9%) |
| Sep 1998 | - | -$46.27M(-165.8%) | -$145.32M(-31.3%) |
| Jun 1998 | - | -$17.41M(-28.6%) | -$110.65M(-6.8%) |
| Mar 1998 | - | -$13.54M(+80.1%) | -$103.64M(-3.4%) |
| Dec 1997 | -$100.15M(-168.4%) | -$68.10M(-487.1%) | -$100.20M(-128.2%) |
| Sep 1997 | - | -$11.60M(-11.5%) | -$43.90M(-7.9%) |
| Jun 1997 | - | -$10.40M(-3.0%) | -$40.70M(-1.0%) |
| Mar 1997 | - | -$10.10M(+14.4%) | -$40.30M(-8.0%) |
| Dec 1996 | -$37.31M(+41.9%) | -$11.80M(-40.5%) | -$37.30M(-10.0%) |
| Sep 1996 | - | -$8.40M(+16.0%) | -$33.90M(+0.3%) |
| Jun 1996 | - | -$10.00M(-40.8%) | -$34.00M(+48.1%) |
| Mar 1996 | - | -$7.10M(+15.5%) | -$65.50M(-2.0%) |
| Dec 1995 | -$64.17M(-137.0%) | -$8.40M(+1.2%) | -$64.20M(-3.0%) |
| Sep 1995 | - | -$8.50M(+79.5%) | -$62.30M(-3.7%) |
| Jun 1995 | - | -$41.50M(-615.5%) | -$60.10M(-131.2%) |
| Mar 1995 | - | -$5.80M(+10.8%) | -$26.00M(+4.1%) |
| Dec 1994 | -$27.08M(-39.2%) | -$6.50M(-3.2%) | -$27.10M(-31.6%) |
| Sep 1994 | - | -$6.30M(+14.9%) | -$20.60M(-44.1%) |
| Jun 1994 | - | -$7.40M(-7.2%) | -$14.30M(-107.2%) |
| Mar 1994 | - | -$6.90M | -$6.90M |
| Dec 1993 | -$19.46M(-38.9%) | - | - |
| Dec 1992 | -$14.01M | - | - |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual net profit?
- What is the all-time high annual net income for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual net income year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly net profit?
- What is the all-time high quarterly net income for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly net income year-on-year change?
- What is Ligand Pharmaceuticals Incorporated TTM net profit?
- What is the all-time high TTM net income for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated TTM net income year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual net profit?
The current annual net income of LGND is -$4.03M
What is the all-time high annual net income for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual net profit is $629.30M
What is Ligand Pharmaceuticals Incorporated annual net income year-on-year change?
Over the past year, LGND annual net profit has changed by -$57.85M (-107.49%)
What is Ligand Pharmaceuticals Incorporated quarterly net profit?
The current quarterly net income of LGND is $4.85M
What is the all-time high quarterly net income for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly net profit is $666.34M
What is Ligand Pharmaceuticals Incorporated quarterly net income year-on-year change?
Over the past year, LGND quarterly net profit has changed by +$56.76M (+109.34%)
What is Ligand Pharmaceuticals Incorporated TTM net profit?
The current TTM net income of LGND is -$75.86M
What is the all-time high TTM net income for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high TTM net profit is $764.38M
What is Ligand Pharmaceuticals Incorporated TTM net income year-on-year change?
Over the past year, LGND TTM net profit has changed by -$118.01M (-280.02%)